NO20074949L - Farmasoytisk preparat som kan administreres oralt for behandling av fisk, fremstillingsmetode for angitte preparat og anvendelse derav - Google Patents

Farmasoytisk preparat som kan administreres oralt for behandling av fisk, fremstillingsmetode for angitte preparat og anvendelse derav

Info

Publication number
NO20074949L
NO20074949L NO20074949A NO20074949A NO20074949L NO 20074949 L NO20074949 L NO 20074949L NO 20074949 A NO20074949 A NO 20074949A NO 20074949 A NO20074949 A NO 20074949A NO 20074949 L NO20074949 L NO 20074949L
Authority
NO
Norway
Prior art keywords
preparation
fish
treatment
administered orally
specified
Prior art date
Application number
NO20074949A
Other languages
English (en)
Inventor
Malte Adelmann
Dieter Fichtner
Bodo Lange
Werner Weitschies
Original Assignee
Riemser Arzneimittel Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riemser Arzneimittel Ag filed Critical Riemser Arzneimittel Ag
Publication of NO20074949L publication Critical patent/NO20074949L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Farming Of Fish And Shellfish (AREA)

Abstract

Foreliggende oppfinnelse gjelder et farmasøytisk preparat som kan tilføres oralt for behandling av fisk, fortrinnsvis for oral vaksinasjon av salmonider. Preparatet inneholder (1) minst én farmakologisk aktiv bestanddel, fortrinnsvis et vaksinestoff, (2) minst ett basisk tilsetningsstoff og (3) minst ett kaldekstruderbart, matriksdannende bærestoff, hvor preparatet er utformet på en slik måte at det i det minste delvis, og fortrinnsvis fullstendig, desintegrerer i surt miljø, nærmere bestemt i fiskemagen. Den nye utformingen anvendes fortrinnsvis for oral immunisering av fisk mot viral, hemoragisk septikemi (VHS) og/eller infeksiøs, hematopoetisk nekrose (IHN). Når preparatet nedbrytes i magen, frigjøres den basiske bestanddel og gir en lokal, midlertidig nøytralisering av magesyren og beskytter således de syresensitive antigenene under passasjen gjennom magen. Preparatet fremstilles fortrinnsvis ved kaldekstrusjon, hvorved en inaktivering av antigenene forhindres.
NO20074949A 2005-03-02 2007-10-01 Farmasoytisk preparat som kan administreres oralt for behandling av fisk, fremstillingsmetode for angitte preparat og anvendelse derav NO20074949L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005010288A DE102005010288A1 (de) 2005-03-02 2005-03-02 Pharmazeutisches, oral applizierbares Präparat zur Behandlung von Fischen, Herstellungsverfahren für dieses und seine Verwendung
PCT/EP2005/013497 WO2006092168A1 (de) 2005-03-02 2005-12-13 Pharmazeutisches, oral applizierbares präparat zur behandlung von fischen, herstellungsverfahren für dieses und seine verwendung

Publications (1)

Publication Number Publication Date
NO20074949L true NO20074949L (no) 2007-11-28

Family

ID=36013614

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074949A NO20074949L (no) 2005-03-02 2007-10-01 Farmasoytisk preparat som kan administreres oralt for behandling av fisk, fremstillingsmetode for angitte preparat og anvendelse derav

Country Status (14)

Country Link
US (1) US8414947B2 (no)
EP (1) EP1853308B1 (no)
JP (1) JP4903166B2 (no)
CN (1) CN101141978B (no)
AT (1) ATE547117T1 (no)
CA (1) CA2599831C (no)
DE (1) DE102005010288A1 (no)
DK (1) DK1853308T3 (no)
ES (1) ES2382553T3 (no)
NO (1) NO20074949L (no)
PL (1) PL1853308T3 (no)
SI (1) SI1853308T1 (no)
WO (1) WO2006092168A1 (no)
ZA (1) ZA200707193B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101322228B1 (ko) * 2012-05-04 2013-10-28 대한민국 넙치의 바이러스성 출혈성 패혈증 예방용 백신
CN105797149A (zh) * 2016-04-21 2016-07-27 中国水产科学研究院珠江水产研究所 草鱼细菌性败血症和草鱼细菌性赤皮病二联蜂胶灭活疫苗及制备工艺
WO2023183471A1 (en) * 2022-03-24 2023-09-28 Dutch Creek Nymphing, Llc Composition and method of applying same to increase survival of fish following catch-and-release situations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT388565B (de) 1987-12-02 1989-07-25 Koelbl Oskar Verfahren zur vermehrung des erregers der viralen haemorrhagischen septikaemie (vhs) der forellen in warmblueterzellkulturen
AU3353599A (en) * 1998-03-31 1999-10-18 University Of Maryland Biotechnology Institute A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
TWI220904B (en) * 1998-12-03 2004-09-11 Nat Science Council An immortal cell line derived from grouper Epinephelus coioides and its applications therein
CA2396711A1 (en) * 2000-01-27 2001-08-02 Aqua Solution Inc. Composition for intestinal delivery
CN1658767A (zh) * 2002-04-08 2005-08-24 皮尔罗斯系统技术公司 调节生理反应或诱导免疫应答的组合物
GB0216414D0 (en) * 2002-07-15 2002-08-21 Novartis Ag Organic compounds
JP4150631B2 (ja) * 2003-05-30 2008-09-17 川崎三鷹製薬株式会社 魚類冷水病ワクチン

Also Published As

Publication number Publication date
WO2006092168A1 (de) 2006-09-08
ES2382553T3 (es) 2012-06-11
DE102005010288A1 (de) 2006-09-07
JP2008531610A (ja) 2008-08-14
JP4903166B2 (ja) 2012-03-28
CN101141978B (zh) 2012-06-13
EP1853308A1 (de) 2007-11-14
US20080317825A1 (en) 2008-12-25
US8414947B2 (en) 2013-04-09
ZA200707193B (en) 2008-07-30
PL1853308T3 (pl) 2012-09-28
ATE547117T1 (de) 2012-03-15
CA2599831C (en) 2014-09-23
CA2599831A1 (en) 2006-09-08
DK1853308T3 (da) 2012-06-25
SI1853308T1 (sl) 2012-07-31
CN101141978A (zh) 2008-03-12
EP1853308B1 (de) 2012-02-29

Similar Documents

Publication Publication Date Title
NO20060185L (no) Anvendelse av isomalt (blanding av 1,6 GPS og 1,1 GPM) som prebiotikum blant annet for fremstilling av et legemiddel for behandling av tarmsykdommer
ATE430154T1 (de) Amino-substituierte cyclohexan derivate zur behandlung bakterieller infektionen
UY32599A (es) Formulación oral sólida de abt-263
DE60323090D1 (de) 1h-imidazoä4,5-cüchinolinderivate zur behandlung von protein kinase-abhängigen krankheiten
CY1118179T1 (el) Φαρμακευτικη συνθεση
NO20056223L (no) Preparat til behandling av infeksjon hos kveg og svin
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
WO2003077828A3 (en) Novel florfenicol-type antibiotics
JP2009526751A5 (no)
BR0313185A (pt) Probióticos para funções neuromusculares intestinais
EA200701519A1 (ru) Живая аттенуированная ротавирусная вакцина для перорального введения
NO20052362D0 (no) Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner
NO20054180D0 (no) Behandling av bakterielle sykdommer i andedrettsorganene ved lokal tilforsel av fluorkinoloner
CY1120240T1 (el) Απο του στοματος χορηγουμενο παρασκευασμα δισκιου ενωσης τετρακυκλινης
JP2009505991A5 (no)
IL167250A (en) Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases
NO20076405L (no) Anvendelse av 24-nor-UDCA
ATE433459T1 (de) Desoxo-nonadepsipeptide
NO20074949L (no) Farmasoytisk preparat som kan administreres oralt for behandling av fisk, fremstillingsmetode for angitte preparat og anvendelse derav
ATE455789T1 (de) Substituierte nonadepsipeptide
ATE524488T1 (de) Lysobactinamide
SE0401631D0 (sv) New Composition
WO2006079910A3 (en) 0-(3-piperidino-2hydroxypropyl)nicotinic amixodime for treating lesions in the oral cavity
BRPI0507733A (pt) composição para a liberação de um agente hipnótico através da mucosa oral, e, método para tratar um distúrbio do sono em um paciente em necessidade deste
JP2003522782A5 (no)

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: RIEMSER PHARMA GMBH, DE

FC2A Withdrawal, rejection or dismissal of laid open patent application